1. Home
  2. BCIC vs STXS Comparison

BCIC vs STXS Comparison

Compare BCIC & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCIC

BCP Investment Corporation

N/A

Current Price

$6.79

Market Cap

74.1M

Sector

Finance

ML Signal

N/A

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

N/A

Current Price

$0.91

Market Cap

86.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BCIC
STXS
Founded
2006
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.1M
86.4M
IPO Year
2006
2004

Fundamental Metrics

Financial Performance
Metric
BCIC
STXS
Price
$6.79
$0.91
Analyst Decision
Hold
Strong Buy
Analyst Count
4
3
Target Price
★ $9.83
$2.67
AVG Volume (30 Days)
60.1K
★ 843.9K
Earning Date
11-11-2026
11-10-2026
Dividend Yield
★ 16.89%
N/A
EPS Growth
★ 262.50
16.67
EPS
N/A
★ N/A
Revenue
N/A
★ $29,346,617.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$35.42
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$5.78
$0.80
52 Week High
$13.44
$2.86

Technical Indicators

Market Signals
Indicator
BCIC
STXS
Relative Strength Index (RSI) 60.28 40.03
Support Level $5.78 $0.80
Resistance Level $7.70 $1.97
Average True Range (ATR) 0.26 0.10
MACD 0.13 0.02
Stochastic Oscillator 82.79 25.48

Price Performance

Historical Comparison
BCIC
STXS

About BCIC BCP Investment Corporation

BCP Investment Corp is an externally managed, non-diversified closed-end investment company. The company invests in secured term loans, bonds or notes and mezzanine debt in privately-held middle market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt and selected equity investments in privately-held middle market companies.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: